Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma - Poll - MDSpire

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma

  • By

  • Hongan Fei

  • Xichao Wen

  • Wensong Wu

  • HaiPeng Liu

  • Haipeng Xie

  • Yan Wang

  • Kebin Zheng

  • Zhaomu Zeng

  • Zetong Bai

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma

  • by Hongan Fei, Xichao Wen, Wensong Wu, HaiPeng Liu, Haipeng Xie, Yan Wang, Kebin Zheng, Zhaomu Zeng, Zetong Bai

  • June 15, 2026

Related Content

Expert consensus from the Chinese medical association on pharmaceutical management of combined cardio-oncology physician-pharmacist clinics

Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report

Case Report: Long-term maternal and neonatal outcomes after nivolumab therapy in metastatic tonsillar sarcomatoid squamous cell carcinoma